These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 3544863

  • 21. Adrenergic effects on plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits.
    Knudtzon J.
    Horm Metab Res; 1984 Aug; 16(8):415-22. PubMed ID: 6381275
    [Abstract] [Full Text] [Related]

  • 22. Adrenergic modulation of extrarenal potassium disposal in men with end-stage renal disease.
    Allon M, Shanklin N.
    Kidney Int; 1991 Dec; 40(6):1103-9. PubMed ID: 1662320
    [Abstract] [Full Text] [Related]

  • 23. Beta-adrenergic-mediated extrarenal potassium disposal in patients with end-stage renal disease: effect of propranolol.
    Yang WC, Huang TP, Ho LT, Chung HM, Chan YL, Batlle DC.
    Miner Electrolyte Metab; 1986 Dec; 12(3):186-93. PubMed ID: 2873504
    [Abstract] [Full Text] [Related]

  • 24. Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion.
    Campbell PJ, Bolli GB, Cryer PE, Gerich JE.
    N Engl J Med; 1985 Jun 06; 312(23):1473-9. PubMed ID: 2859524
    [Abstract] [Full Text] [Related]

  • 25. Regulation of glucose turnover during exercise in pancreatectomized, totally insulin-deficient dogs. Effects of beta-adrenergic blockade.
    Bjorkman O, Miles P, Wasserman D, Lickley L, Vranic M.
    J Clin Invest; 1988 Jun 06; 81(6):1759-67. PubMed ID: 3290252
    [Abstract] [Full Text] [Related]

  • 26. Role of sympathetic nervous system in glucagon response to insulin hypoglycemia in normal and diabetic rats.
    Patel DG.
    Diabetes; 1984 Dec 06; 33(12):1154-9. PubMed ID: 6389231
    [Abstract] [Full Text] [Related]

  • 27. Adrenergic mechanisms of catecholamine action on glucose homeostasis in man.
    Rizza RA, Cryer PE, Haymond MW, Gerich JE.
    Metabolism; 1980 Nov 06; 29(11 Suppl 1):1155-63. PubMed ID: 7001182
    [Abstract] [Full Text] [Related]

  • 28. No effect of beta-adrenergic blockade on hypoglycaemic effect of glucagon-like peptide-1 (GLP-1) in normal subjects.
    Toft-Nielsen M, Hvidberg A, Hilsted J, Dige-Petersen H, Holst JJ.
    Diabet Med; 1996 Jun 06; 13(6):544-8. PubMed ID: 8799658
    [Abstract] [Full Text] [Related]

  • 29. Effect of adrenergic blockade on glucagon and growth hormone secretion in normal and diabetic children.
    Sperling MA, Voina S.
    Pediatr Res; 1975 Sep 06; 9(9):748-52. PubMed ID: 1202424
    [Abstract] [Full Text] [Related]

  • 30. Plasma catecholamines in exercise induced bronchoconstriction.
    Beil M, Brecht HM, Rasche B.
    Klin Wochenschr; 1977 Jun 15; 55(12):577-81. PubMed ID: 18638
    [Abstract] [Full Text] [Related]

  • 31. Adrenergic regulation of glucagon and insulin secretion during immobilization stress in normal and spontaneously diabetic BB rats.
    Nakhooda AF, Sole MJ, Marliss EB.
    Am J Physiol; 1981 Apr 15; 240(4):E373-8. PubMed ID: 7013496
    [Abstract] [Full Text] [Related]

  • 32. [Effects of alpha and beta receptor blockaders on urinary excretion of sodium and potassium in healthy rats and in those with chronic renal failure].
    Manitius J, Jakubowski Z, Manitius A.
    Pol Arch Med Wewn; 1992 Feb 15; 87(2):112-20. PubMed ID: 1523137
    [Abstract] [Full Text] [Related]

  • 33. Blood levels, clearance rates and effects of epinephrine and norepinephrine on insulin and metabolites during alpha- and beta-adrenergic blockade in cattle in vivo, and in vitro degradation of dopamine in bovine blood.
    Fröhli D, Blum JW.
    Acta Endocrinol (Copenh); 1988 Jun 15; 118(2):245-53. PubMed ID: 2898856
    [Abstract] [Full Text] [Related]

  • 34. Adrenergic modulation of glucagon and insulin secretion in obese and lean humans.
    Atkinson RL, Dahms WT, Bray GA, Sperling MA.
    Horm Metab Res; 1981 May 15; 13(5):249-53. PubMed ID: 7021385
    [Abstract] [Full Text] [Related]

  • 35. Impairment of extrarenal potassium disposal by alpha-adrenergic stimulation.
    Williams ME, Rosa RM, Silva P, Brown RS, Epstein FH.
    N Engl J Med; 1984 Jul 19; 311(3):145-9. PubMed ID: 6330550
    [Abstract] [Full Text] [Related]

  • 36. Atrial natriuretic peptide contributes to physiological control of lipid mobilization in humans.
    Moro C, Crampes F, Sengenes C, De Glisezinski I, Galitzky J, Thalamas C, Lafontan M, Berlan M.
    FASEB J; 2004 May 19; 18(7):908-10. PubMed ID: 15033935
    [Abstract] [Full Text] [Related]

  • 37. Role of alpha-adrenergic hormones in potassium homeostasis in the rat.
    Williams ME, Spokes K, Silva P.
    J Lab Clin Med; 1987 Aug 19; 110(2):245-9. PubMed ID: 3298508
    [Abstract] [Full Text] [Related]

  • 38. Beta adrenergic control of extrarenal potassium disposal. A beta-2 mediated phenomenon.
    Bia MJ, Lu D, Tyler K, De Fronzo RA.
    Nephron; 1986 Aug 19; 43(2):117-22. PubMed ID: 2872603
    [Abstract] [Full Text] [Related]

  • 39. Epinephrine-induced hypoaminoacidemia in normal and diabetic human subjects: effect of beta blockade.
    Shamoon H, Jacob R, Sherwin RS.
    Diabetes; 1980 Nov 19; 29(11):875-81. PubMed ID: 7000585
    [Abstract] [Full Text] [Related]

  • 40. Alpha-adrenoceptor-mediated coronary vasoconstriction is augmented during exercise in experimental diabetes mellitus.
    Setty S, Sun W, Martinez R, Downey HF, Tune JD.
    J Appl Physiol (1985); 2004 Jul 19; 97(1):431-8. PubMed ID: 14978008
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.